VRDN logo

Viridian Therapeutics (VRDN) Long Term Debt

Annual Long Term Debt

$20.20 M
+$15.56 M+334.98%

December 31, 2023


Summary


Performance

VRDN Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRDNbalance sheetmetrics:

Quarterly Long Term Debt

$20.52 M
+$3.04 M+17.36%

September 30, 2024


Summary


Performance

VRDN Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRDNbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

VRDN Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+335.0%+2.6%
3 y3 years-+2.6%
5 y5 years+152.4%+2.6%

VRDN Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+335.0%at high+347.6%
5 y5-yearat high+366.8%at high+505.6%
alltimeall timeat high>+9999.0%at high+1375.4%

Viridian Therapeutics Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$20.52 M(+17.4%)
Jun 2024
-
$17.49 M(-14.0%)
Mar 2024
-
$20.33 M(+0.6%)
Dec 2023
$20.20 M(+335.0%)
$20.20 M(+1.0%)
Sep 2023
-
$20.00 M(+324.7%)
Jun 2023
-
$4.71 M(+0.7%)
Mar 2023
-
$4.68 M(+0.7%)
Dec 2022
$4.64 M(+7.3%)
$4.64 M(+0.7%)
Sep 2022
-
$4.61 M(+0.6%)
Jun 2022
-
$4.58 M(+11.1%)
Sep 2020
-
$4.13 M(-23.3%)
Jun 2020
-
$5.38 M(+58.7%)
Mar 2020
-
$3.39 M(-21.7%)
DateAnnualQuarterly
Dec 2019
$4.33 M(-45.9%)
$4.33 M(-17.7%)
Sep 2019
-
$5.26 M(-14.9%)
Jun 2019
-
$6.18 M(-12.9%)
Mar 2019
-
$7.09 M(-11.4%)
Dec 2018
$8.00 M(-19.3%)
$8.00 M(-10.2%)
Sep 2018
-
$8.91 M(-9.2%)
Jun 2018
-
$9.82 M(-2.0%)
Mar 2018
-
$10.02 M(+1.0%)
Dec 2017
$9.92 M(>+9900.0%)
$9.92 M(+613.3%)
Sep 2017
-
$1.39 M(-25.7%)
Jun 2017
-
$1.87 M(-20.3%)
Mar 2017
-
$2.35 M
Dec 2012
$42.00 K
-

FAQ

  • What is Viridian Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Viridian Therapeutics?
  • What is Viridian Therapeutics annual long term debt year-on-year change?
  • What is Viridian Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Viridian Therapeutics?
  • What is Viridian Therapeutics quarterly long term debt year-on-year change?

What is Viridian Therapeutics annual long term debt?

The current annual long term debt of VRDN is $20.20 M

What is the all time high annual long term debt for Viridian Therapeutics?

Viridian Therapeutics all-time high annual long term debt is $20.20 M

What is Viridian Therapeutics annual long term debt year-on-year change?

Over the past year, VRDN annual long term debt has changed by +$15.56 M (+334.98%)

What is Viridian Therapeutics quarterly long term debt?

The current quarterly long term debt of VRDN is $20.52 M

What is the all time high quarterly long term debt for Viridian Therapeutics?

Viridian Therapeutics all-time high quarterly long term debt is $20.52 M

What is Viridian Therapeutics quarterly long term debt year-on-year change?

Over the past year, VRDN quarterly long term debt has changed by +$523.00 K (+2.62%)